T. Rowe Price Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.4M | Sell |
|
|||||
|
2025
Q2 | $11.3M | Sell |
|
|||||
|
2025
Q1 | $11.4M | Sell |
|
|||||
|
2024
Q4 | $31.6M | Sell |
|
|||||
|
2024
Q3 | $34.1M | Sell |
|
|||||
|
2024
Q2 | $132M | Sell |
|
|||||
|
2024
Q1 | $358M | Sell |
|
|||||
|
2023
Q4 | $341M | Sell |
|
|||||
|
2023
Q3 | $329M | Sell |
|
|||||
|
2023
Q2 | $525M | Sell |
|
|||||
|
2023
Q1 | $506M | Buy |
|
|||||
|
2022
Q4 | $404M | Buy |
|
|||||
|
2022
Q3 | $312M | Buy |
|
|||||
|
2022
Q2 | $236M | Buy |
|
|||||
|
2022
Q1 | $62.8M | Buy |
|
|||||
|
2021
Q4 | $82.7M | Sell |
|
|||||
|
2021
Q3 | $91.5M | Sell |
|
|||||
|
2021
Q2 | $106M | Buy |
|
|||||
|
2021
Q1 | $71.7M | Sell |
|
|||||
|
2020
Q4 | $66.7M | Sell |
|
|||||
|
2020
Q3 | $64.6M | Sell |
|
|||||
|
2020
Q2 | $69.3M | Sell |
|
|||||
|
2020
Q1 | $76.4M | Buy |
|
|||||
|
2019
Q4 | $90M | Buy |
|
|||||
|
2019
Q3 | $75.7M | Buy |
|
|||||
|
2019
Q2 | $78.6M | Sell |
|
|||||
|
2019
Q1 | $80.7M | Sell |
|
|||||
|
2018
Q4 | $62.9M | Buy |
|
|||||
|
2018
Q3 | $73.7M | Buy |
|
|||||
|
2018
Q2 | $56.3M | Buy |
|
|||||
|
2018
Q1 | $47.8M | Buy |
|
|||||
|
2017
Q4 | $47.4M | Buy |
|
|||||
|
2017
Q3 | $42.6M | Buy |
|
|||||
|
2017
Q2 | $35.8M | Buy |
|
|||||
|
2017
Q1 | $30.4M | Buy |
|
|||||
|
2016
Q4 | $22.6M | Sell |
|
|||||
|
2016
Q3 | $25.2M | Buy |
|
|||||
|
2016
Q2 | $23.5M | Buy |
|
|||||
|
2016
Q1 | $15M | Buy |
|
|||||
|
2015
Q4 | $1.16M | Sell |
|
|||||
|
2015
Q3 | $1.25M | Buy |
|
|||||
|
2015
Q2 | $1.37M | Buy |
|
|||||
|
2015
Q1 | $1.14M | Buy |
|
|||||
|
2014
Q4 | $912K | Buy |
|
|||||
|
2014
Q3 | $840K | Buy |
|
|||||
|
2014
Q2 | $677K | Sell |
|
|||||
|
2014
Q1 | $818K | Buy |
|
|||||
|
2013
Q4 | $614K | Sell |
|
|||||
|
2013
Q3 | $840K | Sell |
|
|||||
|
2013
Q2 | $844K | Buy |
|